12:00 AM
Jun 11, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

NeuroStar TMS Therapy System regulatory update

Neuronetics said it received CE mark approval for NeuroStar TMS therapy to treat major depressive disorder...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >